{
    "hands_on_practices": [
        {
            "introduction": "Riboswitches are elegant examples of non-coding RNAs that act as direct sensors of small molecules, regulating gene expression without the need for protein factors. To understand how they function as molecular switches, we must first master the thermodynamics of their interaction with a ligand. This practice will guide you through the derivation of the fundamental dose-response curve from the principles of mass-action equilibrium, revealing the direct relationship between the dissociation constant ($K_D$) and the concentration required for activation .",
            "id": "5158190",
            "problem": "In a cell-free molecular diagnostic assay, a non-coding ribonucleic acid (RNA) riboswitch controls the translation of a fluorescent reporter in response to a small-molecule ligand. The riboswitch aptamer and ligand bind in a single-site, non-cooperative manner at equilibrium. Assume the following foundational facts: (i) at equilibrium, the dissociation constant $K_D$ for a bimolecular binding reaction is given by $K_D = \\frac{[R][L]}{[RL]}$, where $[R]$ is the concentration of unbound riboswitch aptamer, $[L]$ is the free ligand concentration, and $[RL]$ is the concentration of the aptamer–ligand complex; (ii) the fraction of riboswitches in the ligand-bound state determines the probability of the reporter being in the activated state; (iii) normalization sets the reporter activation to $0$ when no ligand is bound and to $1$ when all riboswitches are ligand-bound. The riboswitch has a dissociation constant of $K_D = 1\\,\\mu\\mathrm{M}$ and an empirical Hill coefficient $n=1$.\n\nUsing only mass-action equilibrium and the above definitions, derive an expression for the normalized dose–response curve $A([L])$ giving the steady-state reporter activation as a function of ligand concentration $[L]$ under the assumption $n=1$, starting from the equilibrium expression for $K_D$ and the conservation of total aptamer. Then, compute the ligand concentration $[L]_{1/2}$ at which the activation is half-maximal, i.e., $A([L]_{1/2}) = \\tfrac{1}{2}$. Express your final numeric answer for $[L]_{1/2}$ in micromolar and round to three significant figures.",
            "solution": "The user has provided a problem statement that requires validation before a solution is attempted.\n\n### Step 1: Extract Givens\n- **Binding Model**: A non-coding RNA riboswitch aptamer ($R$) and a small-molecule ligand ($L$) bind in a single-site, non-cooperative manner.\n- **Equilibrium Definition (i)**: The dissociation constant is $K_D = \\frac{[R][L]}{[RL]}$, where $[R]$ is the concentration of unbound riboswitch aptamer, $[L]$ is the free ligand concentration, and $[RL]$ is the concentration of the aptamer-ligand complex.\n- **Activation Definition (ii)**: The normalized activation, denoted as $A([L])$, is equivalent to the fraction of riboswitches in the ligand-bound state.\n- **Normalization (iii)**:\n    - $A([L]=0) = 0$ (no ligand, no activation).\n    - $A([L] \\to \\infty) = 1$ (saturating ligand, full activation).\n- **Constants**:\n    - Dissociation constant: $K_D = 1\\,\\mu\\mathrm{M}$.\n    - Empirical Hill coefficient: $n=1$.\n- **Tasks**:\n    1. Derive the expression for the normalized dose-response curve $A([L])$.\n    2. Compute the ligand concentration $[L]_{1/2}$ at which activation is half-maximal, i.e., $A([L]_{1/2}) = \\frac{1}{2}$.\n- **Required Output Format**: The numerical result for $[L]_{1/2}$ must be in micromolar and rounded to three significant figures.\n\n### Step 2: Validate Using Extracted Givens\n- **Scientifically Grounded**: The problem is firmly grounded in the principles of chemical equilibrium and molecular biology. The model described is the standard single-site binding model (or Langmuir adsorption isotherm), which is fundamental to pharmacology, biochemistry, and molecular diagnostics. The given value for $K_D$ is physically realistic for such interactions.\n- **Well-Posed**: The problem is well-posed. It provides all necessary definitions, constants, and relationships to derive a unique mathematical expression for the dose-response curve and to calculate the requested value, $[L]_{1/2}$. The information that the Hill coefficient $n=1$ is consistent with, and a direct consequence of, the single-site, non-cooperative binding model, reinforcing the problem's internal consistency.\n- **Objective**: The problem is stated in precise, objective language, free of ambiguity or subjective claims.\n\n### Step 3: Verdict and Action\nThe problem statement is **valid** as it is scientifically sound, self-contained, consistent, and well-posed. A solution can be derived from the provided information.\n\n### Derivation and Solution\n\nThe goal is to derive the normalized dose–response curve $A([L])$ and then find the concentration $[L]_{1/2}$ corresponding to half-maximal activation.\n\nAccording to definition (ii), the normalized activation $A([L])$ is the fraction of riboswitches in the ligand-bound state. Let $[R]_T$ be the total concentration of the riboswitch aptamer. The total concentration is the sum of the concentrations of the unbound aptamer, $[R]$, and the ligand-bound aptamer-ligand complex, $[RL]$. This conservation of mass is expressed as:\n$$[R]_T = [R] + [RL]$$\nThe fraction of bound riboswitches is therefore $\\frac{[RL]}{[R]_T}$. We can write the activation function as:\n$$A([L]) = \\frac{[RL]}{[R]_T}$$\nOur goal is to express this fraction as a function of the free ligand concentration, $[L]$. We start with the given equilibrium expression for the dissociation constant, $K_D$:\n$$K_D = \\frac{[R][L]}{[RL]}$$\nFrom the conservation of mass equation, we can express the concentration of unbound aptamer, $[R]$, in terms of the total and bound concentrations:\n$$[R] = [R]_T - [RL]$$\nSubstituting this expression for $[R]$ into the equation for $K_D$:\n$$K_D = \\frac{([R]_T - [RL])[L]}{[RL]}$$\nWe now solve this equation for the fraction $\\frac{[RL]}{[R]_T}$. First, we rearrange to isolate terms involving $[RL]$:\n$$K_D [RL] = ([R]_T - [RL])[L]$$\n$$K_D [RL] = [R]_T [L] - [RL][L]$$\n$$K_D [RL] + [RL][L] = [R]_T [L]$$\nFactor out $[RL]$ from the left-hand side:\n$$[RL](K_D + [L]) = [R]_T [L]$$\nFinally, divide both sides by $[R]_T$ and by $(K_D + [L])$ to obtain the desired fraction:\n$$\\frac{[RL]}{[R]_T} = \\frac{[L]}{K_D + [L]}$$\nThis provides the derived expression for the normalized dose–response curve:\n$$A([L]) = \\frac{[L]}{K_D + [L]}$$\nThis equation is a form of the Hill-Langmuir equation for the case where the Hill coefficient, $n$, is equal to $1$, which is consistent with the problem statement.\n\nNext, we must compute the ligand concentration $[L]_{1/2}$ at which the activation is half-maximal. By definition, this occurs when $A([L]_{1/2}) = \\frac{1}{2}$. We set our derived expression equal to $\\frac{1}{2}$:\n$$\\frac{1}{2} = \\frac{[L]_{1/2}}{K_D + [L]_{1/2}}$$\nTo solve for $[L]_{1/2}$, we cross-multiply:\n$$1 \\cdot (K_D + [L]_{1/2}) = 2 \\cdot [L]_{1/2}$$\n$$K_D + [L]_{1/2} = 2[L]_{1/2}$$\nSubtracting $[L]_{1/2}$ from both sides yields:\n$$K_D = [L]_{1/2}$$\nThis result confirms a fundamental property of single-site binding equilibria: the ligand concentration required to achieve half-maximal binding is numerically equal to the dissociation constant, $K_D$.\n\nThe problem provides the value $K_D = 1\\,\\mu\\mathrm{M}$. Therefore:\n$$[L]_{1/2} = 1\\,\\mu\\mathrm{M}$$\nThe problem requests the final answer to be expressed in micromolar and rounded to three significant figures.\n$$[L]_{1/2} = 1.00\\,\\mu\\mathrm{M}$$\nThe numerical value for the final answer is $1.00$.",
            "answer": "$$\\boxed{1.00}$$"
        },
        {
            "introduction": "While some non-coding RNAs act by binding, others, known as ribozymes, possess catalytic activity. Quantifying this activity is essential for their application in diagnostics and therapeutics. This exercise extends the principles of enzyme kinetics, famously described by the Michaelis–Menten model for proteins, to the world of catalytic RNA, allowing you to derive the rate law and understand the meaning of key parameters like $k_{\\text{cat}}$ and $K_m$ in the context of a ribozyme-based assay .",
            "id": "5158168",
            "problem": "A ribonucleic acid (RNA) enzyme (ribozyme) is deployed in a molecular immunodiagnostics assay to detect a target non-coding RNA (ncRNA), such as a microRNA (miRNA). The ribozyme binds the RNA substrate and catalyzes a single-turnover cleavage reaction that generates a measurable signal. Assume a minimal catalytic mechanism consistent with mass-action kinetics and the quasi-steady-state approximation: the ribozyme ($E$) binds substrate ($S$) to form the complex ($ES$), which irreversibly proceeds to product ($P$) with catalytic rate constant $k_{\\text{cat}}$; the binding step is reversible with association rate constant $k_{\\text{on}}$ and dissociation rate constant $k_{\\text{off}}$. The total ribozyme concentration is $[E]_{T}$. Starting from these fundamental kinetic principles and the definition of the Michaelis constant $K_{m}$ as the composite parameter of the binding and catalytic steps, derive the Michaelis–Menten-like initial rate law $v([S])$ for this ribozyme. Then, for an assay configured with $k_{\\text{cat}}=0.1\\,\\text{s}^{-1}$, $K_{m}=1\\,\\mu\\text{M}$, and $[E]_{T}=10\\,\\text{nM}$, compute the initial rate $v$ at $[S]=K_{m}$. Express the final rate in $\\text{M}\\,\\text{s}^{-1}$ and round your answer to three significant figures.",
            "solution": "The scenario is a catalytic RNA (ribozyme) acting on an RNA substrate in a diagnostic context. We begin from a fundamental kinetic scheme that is standard for enzyme catalysis and is applicable to ribozymes:\n$$\nE + S \\xrightleftharpoons[k_{\\text{off}}]{k_{\\text{on}}} ES \\xrightarrow{k_{\\text{cat}}} E + P.\n$$\nThe law of mass action gives the dynamical equations for the complex formation and decay. Under the quasi-steady-state approximation, the concentration of the enzyme–substrate complex $[ES]$ is assumed to reach a steady value on the timescale of the initial rate measurement, such that\n$$\n\\frac{d[ES]}{dt} \\approx 0.\n$$\nThe rate of change of $[ES]$ is\n$$\n\\frac{d[ES]}{dt} = k_{\\text{on}}[E][S] - k_{\\text{off}}[ES] - k_{\\text{cat}}[ES] = 0.\n$$\nSolving for $[ES]$ in terms of $[E]$ and $[S]$,\n$$\nk_{\\text{on}}[E][S] = (k_{\\text{off}} + k_{\\text{cat}})[ES] \\quad \\Rightarrow \\quad [ES] = \\frac{k_{\\text{on}}}{k_{\\text{off}} + k_{\\text{cat}}}[E][S].\n$$\nDefine the Michaelis constant\n$$\nK_{m} \\equiv \\frac{k_{\\text{off}} + k_{\\text{cat}}}{k_{\\text{on}}}.\n$$\nThis yields\n$$\n[ES] = \\frac{[E][S]}{K_{m}}.\n$$\nWe relate the free enzyme concentration $[E]$ to the total enzyme concentration $[E]_{T}$ via conservation of mass:\n$$\n[E]_{T} = [E] + [ES] \\quad \\Rightarrow \\quad [E] = [E]_{T} - [ES].\n$$\nSubstitute $[E] = [E]_{T} - [ES]$ into $[ES] = \\frac{[E][S]}{K_{m}}$:\n$$\n[ES] = \\frac{([E]_{T} - [ES])[S]}{K_{m}}.\n$$\nSolve for $[ES]$ algebraically:\n$$\n[ES]\\left(1 + \\frac{[S]}{K_{m}}\\right) = \\frac{[E]_{T}[S]}{K_{m}} \\quad \\Rightarrow \\quad [ES] = \\frac{[E]_{T}[S]}{K_{m} + [S]}.\n$$\nThe initial rate $v$ is the product formation rate at the outset, which equals the catalytic turnover of the complex:\n$$\nv = k_{\\text{cat}}[ES] = k_{\\text{cat}} \\frac{[E]_{T}[S]}{K_{m} + [S]}.\n$$\nThis is the Michaelis–Menten-like rate law for a ribozyme with saturable substrate binding under the stated assumptions.\n\nWe now evaluate $v$ at $[S]=K_{m}$ with the given parameters $k_{\\text{cat}}=0.1\\,\\text{s}^{-1}$, $K_{m}=1\\,\\mu\\text{M}$, and $[E]_{T}=10\\,\\text{nM}$. Substituting $[S]=K_{m}$ into the rate law,\n$$\nv([S]=K_{m}) = k_{\\text{cat}} \\frac{[E]_{T}K_{m}}{K_{m} + K_{m}} = k_{\\text{cat}} \\frac{[E]_{T}}{2}.\n$$\nConvert concentrations to consistent units in $\\text{M}$:\n$$\n[E]_{T} = 10\\,\\text{nM} = 10 \\times 10^{-9}\\,\\text{M}.\n$$\nCompute $v$:\n$$\nv = 0.1\\,\\text{s}^{-1} \\times \\frac{10 \\times 10^{-9}\\,\\text{M}}{2} = 0.1 \\times \\frac{10}{2} \\times 10^{-9}\\,\\text{M}\\,\\text{s}^{-1} = 0.5 \\times 10^{-9}\\,\\text{M}\\,\\text{s}^{-1}.\n$$\nExpress in standard scientific notation and round to three significant figures:\n$$\nv = 5.00 \\times 10^{-10}\\,\\text{M}\\,\\text{s}^{-1}.\n$$",
            "answer": "$$\\boxed{5.00 \\times 10^{-10}}$$"
        },
        {
            "introduction": "The true power of understanding non-coding and catalytic RNA lies in our ability to engineer them for new purposes, a cornerstone of synthetic biology. This final practice challenges you to think like a molecular engineer by designing a 'toehold switch'—a sophisticated riboregulator for viral RNA detection. You will not only establish the critical sequence design rules but also derive the activation profile, which demonstrates how binding equilibria behave in the non-ideal, concentrated conditions typical of cell-free diagnostic systems .",
            "id": "5158214",
            "problem": "A non-coding riboregulatory device known as a toehold switch is engineered to detect a viral RNA trigger and control translation of a reporter. The toehold switch messenger ribonucleic acid (mRNA) is designed such that the ribosome binding site (RBS) and start codon are sequestered in a hairpin in the absence of trigger, and become accessible upon trigger binding via toehold-mediated strand displacement. You are asked to do two things.\n\nPart A (design rules): Starting from the Central Dogma and base-pairing thermodynamics, construct a set of sequence design rules that ensure high specificity to the viral trigger, low leak translation in the absence of trigger, robust activation upon trigger binding, and compatibility with molecular diagnostics. Your rules must be justified from first principles and include explicit, quantitative sequence constraints. At minimum, they must address: complementarity to the target viral region, the length and accessibility of the toehold, the stability window of the sequestering hairpin, avoidance of off-target interactions (including unintended start codons and secondary structure in the trigger), orthogonality to the host transcriptome, and the optional inclusion of a self-cleaving catalytic ribozyme to standardize the $5^{\\prime}$ end. Provide each rule as a precise constraint (for example, bounds on free energies, guanine-cytosine content ranges, or minimal edit distances).\n\nPart B (activation calculation): Model toehold activation by one-to-one binding of trigger RNA $T$ to switch RNA $S$ to form the active complex $ST$. Assume a single binding site, no cooperativity, and rapid equilibrium relative to translation initiation. Let the dissociation constant be $K_{D}$, with mass action at equilibrium and conservation of total concentrations $S_{0}$ and $T_{0}$. Let the per-mRNA translation initiation rates be $\\alpha_{0}$ when unbound and $\\alpha_{1}$ when bound, and assume steady-state reporter flux is proportional to the mole fraction of $S$ that is bound.\n\nUsing only the law of mass action and the above assumptions, derive from first principles and compute the total trigger concentration $T_{0,1/2}$ that yields half-maximal translation activation. Use the following model parameters for a diagnostically relevant deployment in a cell-free system: $K_{D} = 8.35\\ \\text{nM}$, $S_{0} = 13.0\\ \\text{nM}$, $\\alpha_{0} = 0.030\\ \\text{s}^{-1}$, and $\\alpha_{1} = 1.50\\ \\text{s}^{-1}$. Express the final concentration in nanomolar and round your answer to four significant figures.",
            "solution": "This problem is divided into two parts. Part A requires the formulation of design principles for a toehold switch, justified from first principles. Part B requires the derivation and calculation of the trigger concentration needed for half-maximal activation of the switch. Both parts are addressed below.\n\n### Part A: Sequence Design Rules for a Toehold Switch\n\nA robust and specific toehold switch design must satisfy several competing constraints. The following rules, grounded in the thermodynamics of nucleic acid hybridization and the principles of molecular biology, provide a quantitative framework for engineering these devices.\n\n**Rule 1: Target Specificity and Trigger Region Selection**\n*   **Justification:** The primary function of the switch is to detect a specific viral RNA. This requires the switch's binding site to be perfectly complementary to a unique region of the target viral genome. Specificity is compromised if the target sequence has significant homology to other regions in the viral genome or, more importantly, to sequences in the host organism's transcriptome or other co-existing microbes. The Central Dogma dictates that this RNA sequence is derived from the viral genetic material.\n*   **Constraints:**\n    1.  The chosen trigger sequence, typically $15$–$40$ nucleotides ($nt$) long, must have a perfect reverse complement in the switch's binding domain.\n    2.  The trigger sequence must be unique. A search using a tool like BLASTn against the relevant host (e.g., human) transcriptome database should return no significant hits. A quantitative threshold could be an E-value $> 10$ and a maximum sequence identity $< 80\\%$ over any $15$-$nt$ window.\n    3.  Within the viral genome itself, the sequence should be conserved across strains of interest but unique enough to avoid cross-activation by other viral genes.\n    4.  To ensure high specificity against near-cognate sequences, the designed switch should have a minimal edit distance of $d \\geq 3$ to any other potential off-target sequences in the system.\n\n**Rule 2: Toehold Length and Accessibility**\n*   **Justification:** The toehold is a short, single-stranded region at the $5^{\\prime}$ end of the switch RNA. It serves as the initial nucleation site for trigger binding. Its length is critical: it must be long enough to ensure stable initial binding, but short enough to prevent non-specific binding and to minimize its own secondary structure formation. Accessibility is paramount; if the toehold is sequestered in a secondary structure, the initial binding event is kinetically hindered.\n*   **Constraints:**\n    1.  The toehold length $L_{T}$ should be between $5$ and $15$ $nt$. Shorter toeholds may have insufficient binding energy for efficient nucleation, while longer ones increase the chance of non-specific interactions.\n    2.  The toehold sequence must be predicted to be single-stranded. Using RNA secondary structure prediction software (e.g., NUPACK, ViennaRNA), the ensemble-averaged probability of any nucleotide in the toehold being unpaired should exceed $p > 0.9$. Equivalently, the predicted minimum free energy ($\\Delta G^{\\circ}$) structure for the isolated toehold sequence should be an open chain with $\\Delta G^{\\circ} \\approx 0$ kcal/mol.\n\n**Rule 3: Hairpin Stability (OFF-State Control)**\n*   **Justification:** In the absence of the trigger RNA, the switch must remain in a translationally 'OFF' state. This is achieved by sequestering the Ribosome Binding Site (RBS) and the start codon (typically AUG) within a stable hairpin structure. The stability of this hairpin directly controls the amount of 'leak' translation. If the hairpin is too weak, it will spontaneously 'breathe' or denature, transiently exposing the RBS and leading to background signal. If it is too strong, the energy provided by trigger binding may be insufficient to open it.\n*   **Constraints:**\n    1.  The Gibbs free energy of formation for the sequestering hairpin stem at the operational temperature (e.g., $37^\\circ$C or $310.15$ K) should be within a specific window. A typical target is $\\Delta G^{\\circ}_{hairpin} \\in [-40, -20]$ kcal/mol.\n    2.  The Guanine-Cytosine (GC) content of the hairpin stem should be managed, typically in the range of $50\\%-70\\%$, to achieve this stability without creating overly stable local regions that resist strand displacement.\n    3.  The RBS sequence and the start codon must be fully contained within the base-paired region of the stem.\n\n**Rule 4: Favorable Strand Displacement Energetics (ON-State Activation)**\n*   **Justification:** Activation requires a toehold-mediated strand displacement reaction where the trigger RNA binds to the switch and displaces the intramolecular strand that sequesters the RBS. This overall process must be thermodynamically favorable, meaning the Gibbs free energy change for the reaction must be negative. The final switch-trigger complex is a long intermolecular duplex, which should be significantly more stable than the initial intramolecular hairpin of the switch.\n*   **Constraints:**\n    1.  The overall free energy change for the binding reaction, $\\Delta G^{\\circ}_{rxn} = \\Delta G^{\\circ}_{ST\\_complex} - \\Delta G^{\\circ}_{S\\_hairpin}$, must be strongly negative, ideally $\\Delta G^{\\circ}_{rxn} < -10$ kcal/mol.\n    2.  The binding region of the switch is complementary to the trigger sequence. The stability of this intermolecular duplex ($\\Delta G^{\\circ}_{ST\\_complex}$) must be greater (more negative) than the stability of the intramolecular hairpin stem it displaces ($\\Delta G^{\\circ}_{S\\_hairpin}$).\n\n**Rule 5: Avoidance of Spurious Structures and Signals**\n*   **Justification:** The switch mRNA and the target trigger RNA are functional molecules whose activities are defined by their structures. Unintended secondary structures or sequence motifs can interfere with proper function.\n*   **Constraints:**\n    1.  The switch sequence, outside of the designed hairpin, should not contain stable secondary structures ($\\Delta G^{\\circ} > -5$ kcal/mol) that could interfere with folding or ribosome transit.\n    2.  The sequence should be scanned for and cleared of any cryptic start codons (AUG, GUG, UUG) that are in-frame with the reporter gene's open reading frame, which could lead to truncated or aberrant protein products.\n    3.  The target region on the viral RNA trigger should itself be relatively unstructured. The accessibility of the target site can be scored using tools like RNAplfold, with a desired average open probability $p > 0.5$. A highly structured target site will incur a significant energetic penalty to unfold before binding the switch, reducing the effective binding affinity.\n\n**Rule 6: Orthogonality to the Host System**\n*   **Justification:** When deployed in a biological context (in vivo or in cell extracts), the switch RNA must not interact with endogenous components of the system, such as microRNAs (miRNAs) or other non-coding RNAs, which could sequester the switch or trigger non-specific cellular responses. This is the principle of orthogonality.\n*   **Constraints:**\n    1.  The toehold and binding region sequences must be checked for complementarity to known miRNAs in the host organism. There should be no seed-region matches ($7$-$8$ $nt$) to abundant miRNAs.\n    2.  As stated in Rule 1, the full switch sequence should be subjected to a BLAST search against the host transcriptome to ensure minimal homology.\n\n**Rule 7: Standardization via a Self-Cleaving Ribozyme**\n*   **Justification:** For molecular diagnostics, reproducibility and standardization are key. In vitro transcription, a common method for producing RNA, can generate molecules with heterogeneous $5^{\\prime}$ and $3^{\\prime}$ ends. A variable $5^{\\prime}$ end is particularly problematic because it can alter the length and accessibility of the toehold. Placing a cis-acting, self-cleaving ribozyme (a catalytic RNA) at the $5^{\\prime}$ end of the transcript ensures that all switch molecules have an identical, precisely defined $5^{\\prime}$ terminus post-cleavage.\n*   **Constraints:**\n    1.  A well-characterized ribozyme sequence (e.g., hammerhead, pistol, or twister ribozyme) is inserted into the DNA template for transcription directly upstream of the toehold switch sequence.\n    2.  The ribozyme must be chosen and oriented such that its self-cleavage site corresponds exactly to the intended $5^{\\prime}$ nucleotide of the toehold switch. The cleavage reaction should be efficient under the conditions of RNA production or the diagnostic assay.\n\n### Part B: Calculation of Half-Maximal Activation Trigger Concentration\n\nWe are asked to derive an expression for the total trigger concentration, $T_{0,1/2}$, that results in half-maximal translation activation.\n\n**1. Define the System and Equilibrium**\nThe binding of trigger RNA, $T$, to switch RNA, $S$, forms the active complex $ST$:\n$$ S + T \\rightleftharpoons ST $$\nAt equilibrium, the dissociation constant $K_D$ is given by the law of mass action:\n$$ K_D = \\frac{[S][T]}{[ST]} $$\nwhere $[S]$, $[T]$, and $[ST]$ are the equilibrium concentrations of the free switch, free trigger, and the complex, respectively.\n\nThe total concentrations, $S_0$ and $T_0$, are conserved:\n$$ S_0 = [S] + [ST] $$\n$$ T_0 = [T] + [ST] $$\n\n**2. Define Half-Maximal Activation**\nThe total reporter flux, $J$, is the sum of contributions from the unbound (leaky) and bound (activated) switch populations. The flux from each population is proportional to its concentration and its per-molecule translation initiation rate.\n$$ J = c \\cdot (\\alpha_0 [S] + \\alpha_1 [ST]) $$\nwhere $c$ is a proportionality constant.\n\nUsing the conservation of $S$, we can express $[S]$ as $S_0 - [ST]$:\n$$ J = c \\cdot (\\alpha_0 (S_0 - [ST]) + \\alpha_1 [ST]) = c \\cdot (\\alpha_0 S_0 + (\\alpha_1 - \\alpha_0)[ST]) $$\nThe flux is a linear function of the concentration of the active complex, $[ST]$.\n\nThe minimum flux, $J_{min}$, occurs when there is no trigger, so $T_0 = 0$ and $[ST] = 0$:\n$$ J_{min} = c \\cdot \\alpha_0 S_0 $$\nThe maximum theoretical flux, $J_{max}$, occurs when all switch molecules are bound, which happens as $T_0 \\to \\infty$, causing $[ST] \\to S_0$:\n$$ J_{max} = c \\cdot (\\alpha_0 (S_0 - S_0) + \\alpha_1 S_0) = c \\cdot \\alpha_1 S_0 $$\nHalf-maximal activation corresponds to the flux level that is halfway between the minimum and maximum:\n$$ J_{1/2} = J_{min} + \\frac{1}{2}(J_{max} - J_{min}) = \\frac{J_{min} + J_{max}}{2} $$\n$$ J_{1/2} = \\frac{c \\cdot \\alpha_0 S_0 + c \\cdot \\alpha_1 S_0}{2} = \\frac{c S_0 (\\alpha_0 + \\alpha_1)}{2} $$\nWe find the concentration of the complex, $[ST]_{1/2}$, that produces this flux by setting $J = J_{1/2}$:\n$$ c \\cdot (\\alpha_0 S_0 + (\\alpha_1 - \\alpha_0)[ST]_{1/2}) = \\frac{c S_0 (\\alpha_0 + \\alpha_1)}{2} $$\nDividing by $c$ and rearranging:\n$$ (\\alpha_1 - \\alpha_0)[ST]_{1/2} = \\frac{S_0 (\\alpha_0 + \\alpha_1)}{2} - \\alpha_0 S_0 = \\frac{S_0 \\alpha_0 + S_0 \\alpha_1 - 2 S_0 \\alpha_0}{2} = \\frac{S_0 (\\alpha_1 - \\alpha_0)}{2} $$\nAssuming $\\alpha_1 \\neq \\alpha_0$ (i.e., the switch actually works), we can divide by $(\\alpha_1 - \\alpha_0)$:\n$$ [ST]_{1/2} = \\frac{S_0}{2} $$\nThus, half-maximal activation occurs when exactly half of the total switch RNA molecules are in the active, trigger-bound state.\n\n**3. Derive the Expression for $T_{0,1/2}$**\nNow we solve for the total trigger concentration $T_{0,1/2}$ that satisfies this condition.\nAt this point, we have:\n$$ [ST]_{1/2} = \\frac{S_0}{2} $$\nFrom the conservation of $S$, the free switch concentration is:\n$$ [S]_{1/2} = S_0 - [ST]_{1/2} = S_0 - \\frac{S_0}{2} = \\frac{S_0}{2} $$\nNow substitute these concentrations into the expression for $K_D$ to find the free trigger concentration, $[T]_{1/2}$:\n$$ K_D = \\frac{[S]_{1/2} [T]_{1/2}}{[ST]_{1/2}} = \\frac{(S_0/2) [T]_{1/2}}{(S_0/2)} = [T]_{1/2} $$\nSo, the free trigger concentration required for half-maximal activation is equal to the dissociation constant, $K_D$.\n\nFinally, using the conservation of $T$, we find the total trigger concentration $T_{0,1/2}$:\n$$ T_{0,1/2} = [T]_{1/2} + [ST]_{1/2} $$\nSubstituting the derived expressions for $[T]_{1/2}$ and $[ST]_{1/2}$:\n$$ T_{0,1/2} = K_D + \\frac{S_0}{2} $$\nThis is the symbolic expression for the total trigger concentration yielding half-maximal activation.\n\n**4. Numerical Calculation**\nWe are given the following parameters:\n$K_D = 8.35$ nM\n$S_0 = 13.0$ nM\nThe translation rates $\\alpha_0 = 0.030 \\text{ s}^{-1}$ and $\\alpha_1 = 1.50 \\text{ s}^{-1}$ were used to define the condition for half-maximal activation but are not needed for the final calculation.\n\nSubstituting the numerical values into our derived expression:\n$$ T_{0,1/2} = 8.35 \\text{ nM} + \\frac{13.0 \\text{ nM}}{2} $$\n$$ T_{0,1/2} = 8.35 \\text{ nM} + 6.5 \\text{ nM} $$\n$$ T_{0,1/2} = 14.85 \\text{ nM} $$\nThe result $14.85$ has four significant figures as required.",
            "answer": "$$\\boxed{14.85}$$"
        }
    ]
}